SCHEMBL7841310

SCHEMBL7841310

CC(=O)c1ccc(C(=O)Nc2ccccc2)c2ccccc12

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.63
KMT2A Q03164 4/20 0.63
HPGD P15428 3/20 0.58
ALDH1A1 P00352 1/20 0.56
HSD17B10 Q99714 2/20 0.55
HTT P42858 2/20 0.55
KDM4E B2RXH2 1/20 0.55
LMNA P02545 1/20 0.55
TP53 P04637 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.54
NAPRT Q6XQN6 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
NPC1 O15118 2/20 0.53
RAB9A P51151 2/20 0.53
AKR1C4 P17516 1/20 0.52
AKR1C3 P42330 1/20 0.52
AKR1C2 P52895 1/20 0.52
AKR1C1 Q04828 1/20 0.52
METAP2 P50579 1/20 0.51
CYP3A4 P08684 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10055004 0.92 MEN1 (0.71) MEN1KMT2AHPGDALDH1A1HSD17B10
SCHEMBL7539086 0.84 MEN1 (0.62) MEN1KMT2AHPGDALDH1A1HSD17B10
SCHEMBL9416238 0.82 MEN1 (0.59) MEN1KMT2AHPGDALDH1A1HSD17B10
SCHEMBL10391045 0.82 KDM4E (0.55) MEN1KMT2AHPGDALDH1A1KDM4E
SCHEMBL38471077 0.82 KDM4E (0.55) MEN1KMT2AHPGDALDH1A1KDM4E
SCHEMBL7544097 0.80 MEN1 (0.56) MEN1KMT2AHPGDALDH1A1HSD17B10
SCHEMBL982547 0.78 NR4A1 (0.54) MEN1KMT2AHPGDALDH1A1HSD17B10
SCHEMBL31396473 0.78 NR4A1 (0.54) MEN1KMT2AHPGDALDH1A1HSD17B10
SCHEMBL31150345 0.78 DEGS1 (0.78) MEN1KMT2AHPGDALDH1A1HSD17B10
SCHEMBL368228 0.78 DEGS1 (0.78) MEN1KMT2AHPGDALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6288232-B2 REACTION OF ACETYLNAPHTHALIC ANHYDRIDE AND ALDEHYDE IN THE PRESENCE OF AQUEOUS BASE AND BOILING IN THE PRESENCE OF ANILINE COMPOUND EMAGIN CORPORATION 2001-09-11 US disclosed
US-20010012905-A1 Synthesis of pyrazolinylnaphthalic acid derivatives EMAGIN CORPORATION 2001-08-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010012905-A1 Synthesis of pyrazolinylnaphthalic acid derivatives AHR, NAT1, ARSA MEN1 4783/4885KMT2A 2529/4885HPGD 1580/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.